|
Feb 11
|
Microbot Medical Closes $13 Million Registered Direct Offering
|
|
Feb 10
|
Microbot Medical Announces $13 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
|
|
Dec 30
|
Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY®
|
|
Dec 11
|
Microbot Medical seeks FDA clearance for endovascular robotic system
|
|
Dec 10
|
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access
|
|
Dec 10
|
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System
|